TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00111397 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00052377 — Safety Biomarker (SAF): Interleukin 12
Study NCT00052377 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00611364 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01801501 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT00573443 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT04599998 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04599998 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05181969 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01386151 — Predictive Biomarker (PRD): FGF7 mRNA
Genes: FGF7; KGF
Study NCT01880515 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01880515 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06736626 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT02306200 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study NCT03988595 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01767974 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00147433 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT02442297 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06295666 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study NCT02099513 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05086003 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04121273 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT02165007 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00910221 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01286545 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01290718 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03356860 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01899755 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03911037 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03911037 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT02488408 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study NCT03183609 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT02412085 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03791489 — Predictive Biomarker (PRD): PNN mRNA
Genes: PNN; DRS; MEMA
Study NCT04055285 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01851421 — Predictive Biomarker (PRD): MC3R mRNA
Genes: MC3R
Study NCT00250419 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT03956576 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03818659 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01676142 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT01514045 — Predictive Biomarker (PRD): Epithelial cadherin
Genes: CDH1; CDHE; UVO
Study NCT02031744 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03888365 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03296722 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03285594 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02213263 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00224718 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01440803 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02358538 — Predictive Biomarker (PRD): PCDH19 mRNA
Genes: PCDH19; KIAA1313
Study NCT02659150 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01966666 — Predictive Biomarker (PRD): TPI1 mRNA
Genes: TPI1; TPI
Study NCT02228421 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02228421 — Predictive Biomarker (PRD): EML4 mRNA
Genes: EML4; C2orf2; EMAPL4
Study NCT02228421 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02556723 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00382980 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03563872 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02278757 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01910558 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02652169 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02588339 — Predictive Biomarker (PRD): PANO1 mRNA
Genes: PANO1; PANO
Study NCT03076437 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03076437 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT02709018 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04363554 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT01667120 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03354299 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study NCT03354299 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00228579 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02261389 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT03608020 — Predictive Biomarker (PRD): BMX mRNA
Genes: BMX
Study NCT01168258 — Predictive Biomarker (PRD): PLXNA2 mRNA
Genes: PLXNA2; KIAA0463; OCT; PLXN2; UNQ209/PRO235
Study NCT01299935 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03174964 — Predictive Biomarker (PRD): KLRD1 mRNA
Genes: KLRD1; CD94
Study NCT04362462 — Predictive Biomarker (PRD): SLC13A5 mRNA
Genes: SLC13A5; NACT
Study NCT04362462 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study NCT03810586 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00506831 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00506831 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02407548 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT02744287 — Predictive Biomarker (PRD): PSCA mRNA
Genes: PSCA; UNQ206/PRO232
Study NCT00529464 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT02373293 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT02331368 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06693024 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06693024 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03785886 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00081471 — Surrogate Endpoint (SUR): Hemoglobin response rate
Study NCT02243852 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT02834650 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02360514 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01774591 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01901549 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03952065 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03952065 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03952065 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT02572713 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT02991274 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01603940 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02942563 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT02748564 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03676946 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT01197391 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02881138 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02901379 — Predictive Biomarker (PRD): FSTL1 mRNA
Genes: FSTL1; FRP
Study NCT02901379 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02901379 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study NCT02748707 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02748707 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02825160 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04515095 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03419403 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03419403 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03179358 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00935012 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT00935012 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT00929734 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00929734 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02216383 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01339481 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study NCT01339481 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study NCT04476511 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02128503 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01895764 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02394886 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02394886 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT02394886 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02348281 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT00593554 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01668875 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03356743 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01411280 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT01876108 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT03994913 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04715295 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00157586 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00316381 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00316381 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT03603522 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT01855750 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT02673762 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT02984696 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01602939 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT01724515 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study NCT03534063 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03089515 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02224586 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT04467151 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01331811 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00781053 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study NCT00866905 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04445402 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00880009 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05798208 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04266197 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03986697 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03986697 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00221299 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03749187 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT01614470 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02127463 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00157053 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT02911701 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01604941 — Predictive Biomarker (PRD): Liver iron
Study NCT03972332 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02518945 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT02518945 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01490372 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00844987 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00844987 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT00844987 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03456466 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02408367 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02408367 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02408367 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02312154 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02993159 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03861247 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00714935 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03254225 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00681005 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01940874 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03004703 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02355015 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT05701943 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00741780 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00741780 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00042783 — Predictive Biomarker (PRD): MAGEA3 mRNA
Genes: MAGEA3; MAGE3
Study NCT02528279 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT04440436 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02569892 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04378621 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01640197 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03964935 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT03964935 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT03964935 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study NCT03964935 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT02973867 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00418938 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02698579 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study NCT00056290 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00056290 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01499810 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01499810 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01555658 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT04452604 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02873832 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT02873832 — Predictive Biomarker (PRD): HSPB1 mRNA
Genes: HSPB1; HSP27; HSP28
Study NCT00570635 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT03664115 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03664115 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03664115 — Predictive Biomarker (PRD): Hypoxia-inducible factor 1-alpha
Genes: HIF1A; BHLHE78; MOP1; PASD8
Study NCT01765361 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02193724 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study NCT04356508 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00100906 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00376480 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00470704 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02602249 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT02794961 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT01757080 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01757080 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01757080 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00672152 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT00672152 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03311854 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT03311854 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00305760 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03768531 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT02490930 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03250312 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT00940563 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT05846997 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT03375359 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT03577938 — Predictive Biomarker (PRD): CHM mRNA
Genes: CHM; REP1; TCD
Study NCT04280328 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT04102137 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01267162 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01009229 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02823470 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02365662 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02365662 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02185144 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03939897 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03939897 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT03939897 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03612271 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00107991 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04422457 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04422457 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04547309 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00005917 — Predictive Biomarker (PRD): LYST mRNA
Genes: LYST; CHS; CHS1
Study NCT00922844 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00656786 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00656786 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01079845 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01079845 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00433719 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02372448 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04639219 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02888756 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT02888756 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT02888756 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT03713086 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04275479 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study NCT04275479 — Predictive Biomarker (PRD): SBDS mRNA
Genes: SBDS; CGI-97
Study NCT04275479 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT00151229 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01342939 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP